Research ExplorerPublicationsPSA-Anstieg nach definitiver Therapie

PSA-Anstieg nach definitiver Therapie

Standard

PSA-Anstieg nach definitiver Therapie. / Maurer, T; Hadaschik, B; Budäus, L; Steuber, T; Salomon, G; Horn, T; Herrmann, K; Weber, M; Giesel, F L; Berliner, C; Eiber, M.

In: UROLOGE, Vol. 58, No. 5, 05.2019, p. 569-582.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Maurer, T, Hadaschik, B, Budäus, L, Steuber, T, Salomon, G, Horn, T, Herrmann, K, Weber, M, Giesel, FL, Berliner, C & Eiber, M 2019, 'PSA-Anstieg nach definitiver Therapie', UROLOGE, vol. 58, no. 5, pp. 569-582. https://doi.org/10.1007/s00120-019-0931-4

APA

Maurer, T., Hadaschik, B., Budäus, L., Steuber, T., Salomon, G., Horn, T., Herrmann, K., Weber, M., Giesel, F. L., Berliner, C., & Eiber, M. (2019). PSA-Anstieg nach definitiver Therapie. UROLOGE, 58(5), 569-582. https://doi.org/10.1007/s00120-019-0931-4

Vancouver

Maurer T, Hadaschik B, Budäus L, Steuber T, Salomon G, Horn T et al. PSA-Anstieg nach definitiver Therapie. UROLOGE. 2019 May;58(5):569-582. https://doi.org/10.1007/s00120-019-0931-4

Bibtex

@article{8db038f836ba49cda3186f7aff57748e,
title = "PSA-Anstieg nach definitiver Therapie",
abstract = "Following definitive treatment with curative intent a subset of patients with prostate cancer experience biochemical recurrence. In these patients clinical parameters are mostly used to decide if a local or systemic disease recurrence is present. While salvage radiation treatment is advocated for local recurrence after radical prostatectomy, no standard recommendations exist in cases of local recurrence after primary radiation therapy although salvage prostatectomy may be considered. Imaging procedures have traditionally not routinely been recommended for the onset of prostate-specific antigen (PSA) relapse; however, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) exhibits high detection rates even at low PSA values. Thus, the current German guidelines state that PSMA PET/CT can be considered if this could result in a decisive change in further treatment management. Currently, a positive influence on oncological long-term outcome, however, has not yet been proven.",
keywords = "English Abstract, Journal Article",
author = "T Maurer and B Hadaschik and L Bud{\"a}us and T Steuber and G Salomon and T Horn and K Herrmann and M Weber and Giesel, {F L} and C Berliner and M Eiber",
year = "2019",
month = may,
doi = "10.1007/s00120-019-0931-4",
language = "Deutsch",
volume = "58",
pages = "569--582",
journal = "UROLOGE",
issn = "0340-2592",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - PSA-Anstieg nach definitiver Therapie

AU - Maurer, T

AU - Hadaschik, B

AU - Budäus, L

AU - Steuber, T

AU - Salomon, G

AU - Horn, T

AU - Herrmann, K

AU - Weber, M

AU - Giesel, F L

AU - Berliner, C

AU - Eiber, M

PY - 2019/5

Y1 - 2019/5

N2 - Following definitive treatment with curative intent a subset of patients with prostate cancer experience biochemical recurrence. In these patients clinical parameters are mostly used to decide if a local or systemic disease recurrence is present. While salvage radiation treatment is advocated for local recurrence after radical prostatectomy, no standard recommendations exist in cases of local recurrence after primary radiation therapy although salvage prostatectomy may be considered. Imaging procedures have traditionally not routinely been recommended for the onset of prostate-specific antigen (PSA) relapse; however, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) exhibits high detection rates even at low PSA values. Thus, the current German guidelines state that PSMA PET/CT can be considered if this could result in a decisive change in further treatment management. Currently, a positive influence on oncological long-term outcome, however, has not yet been proven.

AB - Following definitive treatment with curative intent a subset of patients with prostate cancer experience biochemical recurrence. In these patients clinical parameters are mostly used to decide if a local or systemic disease recurrence is present. While salvage radiation treatment is advocated for local recurrence after radical prostatectomy, no standard recommendations exist in cases of local recurrence after primary radiation therapy although salvage prostatectomy may be considered. Imaging procedures have traditionally not routinely been recommended for the onset of prostate-specific antigen (PSA) relapse; however, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) computed tomography (CT) exhibits high detection rates even at low PSA values. Thus, the current German guidelines state that PSMA PET/CT can be considered if this could result in a decisive change in further treatment management. Currently, a positive influence on oncological long-term outcome, however, has not yet been proven.

KW - English Abstract

KW - Journal Article

U2 - 10.1007/s00120-019-0931-4

DO - 10.1007/s00120-019-0931-4

M3 - SCORING: Zeitschriftenaufsatz

C2 - 31049635

VL - 58

SP - 569

EP - 582

JO - UROLOGE

JF - UROLOGE

SN - 0340-2592

IS - 5

ER -